Table 2.
Signal intensities (SIs) over the nodule and adjacent liver parenchyma and the resulting percentage signal ratio (PSR) for each contrast-enhanced phase. Data are presented as median (Q1/Q3)
| Arterial | Portal venous | Equilibrium | Delayed | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nodule (SI) | Liver (SI) | PSR | Nodule (SI) | Liver (SI) | PSR | Nodule (SI) | Liver (SI) | PSR | Nodule (SI) | Liver (SI) | PSR | |
| Non-HCC | 255.5 (197.8/345.2) | 183.7 (158.6/260.9) | 76.4 (73.7/81.9) | 302.7 (234.8/346.8) | 275.6 (207.9/321.3) | 90.9 (87.0/95.7) | 306.5 (223.3/352.1) | 284.1 (201.0/328.6) | 93.8 (91.2/97.2) | 329.5 (261.3/569.5) | 235.2 (195.2/424.8) | 96.0 (94.4/98.8) |
| HCC | 211.0 (168.0/291.6) | 156.8 (129.5/208.8) | 73.6 (66.4/82.2) | 249.0 (208.2/303.2) | 261.3 (212.9/322.8) | 106.8 (90.5/121.0) | 229.2 (191.5/283.3) | 272.8 (220.1/322.3) | 116.2 (105.6/126.1) | 251.5 (202.1/309.5) | 212.0 (171.4/266.3) | 112.9 (104.3/124.4) |
| p | <0.001 | 0.233 | 0.005 | <0.001 | ||||||||